GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Dian Diagnostics Group Co Ltd (SZSE:300244) » Definitions » Cyclically Adjusted Revenue per Share

Dian Diagnostics Group Co (SZSE:300244) Cyclically Adjusted Revenue per Share : ¥15.11 (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Dian Diagnostics Group Co Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Dian Diagnostics Group Co's adjusted revenue per share for the three months ended in Mar. 2024 was ¥4.760. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥15.11 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Dian Diagnostics Group Co's average Cyclically Adjusted Revenue Growth Rate was 14.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Dian Diagnostics Group Co was 29.50% per year. The lowest was 25.00% per year. And the median was 27.25% per year.

As of today (2024-06-07), Dian Diagnostics Group Co's current stock price is ¥12.91. Dian Diagnostics Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ¥15.11. Dian Diagnostics Group Co's Cyclically Adjusted PS Ratio of today is 0.85.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dian Diagnostics Group Co was 6.84. The lowest was 0.88. And the median was 3.52.


Dian Diagnostics Group Co Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Dian Diagnostics Group Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dian Diagnostics Group Co Cyclically Adjusted Revenue per Share Chart

Dian Diagnostics Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.89 7.49 9.54 12.78 14.64

Dian Diagnostics Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.25 13.70 14.27 14.64 15.11

Competitive Comparison of Dian Diagnostics Group Co's Cyclically Adjusted Revenue per Share

For the Diagnostics & Research subindustry, Dian Diagnostics Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dian Diagnostics Group Co's Cyclically Adjusted PS Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dian Diagnostics Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Dian Diagnostics Group Co's Cyclically Adjusted PS Ratio falls into.



Dian Diagnostics Group Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Dian Diagnostics Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=4.76/115.2271*115.2271
=4.760

Current CPI (Mar. 2024) = 115.2271.

Dian Diagnostics Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.835 98.200 0.980
201409 0.772 98.900 0.899
201412 0.672 99.000 0.782
201503 0.677 99.900 0.781
201506 0.955 99.500 1.106
201509 0.962 100.500 1.103
201512 1.100 100.600 1.260
201603 1.206 102.200 1.360
201606 1.779 101.400 2.022
201609 1.841 102.400 2.072
201612 2.127 102.600 2.389
201703 1.906 103.200 2.128
201706 2.334 103.100 2.609
201709 2.562 104.100 2.836
201712 2.393 104.500 2.639
201803 2.195 105.300 2.402
201806 3.167 104.900 3.479
201809 3.503 106.600 3.786
201812 3.881 106.500 4.199
201903 2.959 107.700 3.166
201906 3.477 107.700 3.720
201909 3.572 109.800 3.749
201912 3.623 111.200 3.754
202003 2.466 112.300 2.530
202006 4.748 110.400 4.956
202009 4.834 111.700 4.987
202012 5.085 111.500 5.255
202103 4.591 112.662 4.696
202106 4.631 111.769 4.774
202109 5.563 112.215 5.712
202112 6.035 113.108 6.148
202203 7.457 114.335 7.515
202206 9.789 114.558 9.846
202209 7.831 115.339 7.823
202212 7.400 115.116 7.407
202303 5.150 115.116 5.155
202306 5.758 114.558 5.792
202309 5.503 115.339 5.498
202312 5.027 114.781 5.047
202403 4.760 115.227 4.760

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Dian Diagnostics Group Co  (SZSE:300244) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Dian Diagnostics Group Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=12.91/15.11
=0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Dian Diagnostics Group Co was 6.84. The lowest was 0.88. And the median was 3.52.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Dian Diagnostics Group Co Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Dian Diagnostics Group Co's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Dian Diagnostics Group Co (SZSE:300244) Business Description

Traded in Other Exchanges
N/A
Address
No. 329, Jinpeng Street, 5th Floor, Building 2, Xihu District, Zhejiang, Hangzhou, CHN, 310030
Dian Diagnostics Group Co Ltd is an independent third-party medical diagnostic service provider that provides diagnostic services outsourcing as its core business. It promotes the development of multi-service areas of medical diagnostic platforms and integrated development strategies for upstream and downstream industry chains, covering medical diagnostic services and diagnostic products.
Executives
Chen Hai Bin Director
Chen Shi Shi Supervisors
Guo San Hui Executives
Yao Shu Lie Executives
Xu Min Director
Wang Yan Xiao Directors, executives
Chen Zuo Xiu Directors, executives
Hu Yong Director
Hu Miao Shen Executives
Chen Xue Dong Director
Jiang Tang Directors, executives
Tao Jun Securities Affairs Representative
Wu Zheng Xin Executives
Cheng Xiu Li Supervisors

Dian Diagnostics Group Co (SZSE:300244) Headlines

No Headlines